ArticlePharmacology research & perspectives2013

The arylpiperazine derivatives N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide and N-benzyl-4-(2-diphenyl)-1-piperazinehexanamide exert a long-lasting inhibition of human serotonin 5-HT7 receptor binding and cAMP signaling.

Patricio Atanes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.